Consort Medical (CSRMY) Stock Price, News & Analysis

Company Overview

Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is based in Hemel Hempstead, the United Kingdom.

Key Stats

• Today's Range: $10.80 to $10.80
• 50-Day Range: N/A
• 52-Week Range: $13.25 to $16.65
• Volume: 92 shs
• Average Volume: 190 shs
• Market Capitalization: $532.22 million
• P/E Ratio: 12.56
• Dividend Yield: 1.57%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private Households
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CSRMY
• Previous Symbol: NASDAQ:CSRMY
• CIK: N/A
• Web: www.consortmedical.com
• Phone: 44-14-4286-7920
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 12.56
• Forward P/E Ratio: 13.33
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.48
• Current Ratio: 1.91
• Quick Ratio: 0.50

Sales & Book Value

• Annual Sales: $416.41 million
• Price / Sales: 1.28
• Cash Flow: $1.55 per share
• Price / Cash Flow: 6.95
• Book Value: $6.69 per share
• Price / Book: 1.61

Miscellaneous

• Outstanding Shares: 49,280,000
• Free Float: N/A
• Market Cap: $532.22 million
• Optionable: Not Optionable
• Beta: 0.01